Bladder Cancer: Diagnosis and Evaluation: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 79: | Line 79: | ||
** Rarely reveals significant findings in patients with NMIBC. | ** Rarely reveals significant findings in patients with NMIBC. | ||
== | == Labs == | ||
=== '''<span style="color:#ff0000">Urine cytology</span>''' === | === '''<span style="color:#ff0000">Urine cytology</span>''' === | ||
| Line 119: | Line 119: | ||
** Has a 20x higher concentration in the urine of bladder cancer patients than in non-cancer controls. | ** Has a 20x higher concentration in the urine of bladder cancer patients than in non-cancer controls. | ||
** With a cutoff of 10 units/mL, the overall sensitivity and specificity for detecting urothelial cancer were 49% and 87%, respectively | ** With a cutoff of 10 units/mL, the overall sensitivity and specificity for detecting urothelial cancer were 49% and 87%, respectively | ||
== <span style="color:#ff0000">Imaging</span> == | == <span style="color:#ff0000">Imaging</span> == | ||